Inogen Operating Margin from 2010 to 2026

INGN Stock  USD 6.13  0.38  6.61%   
Inogen Operating Profit Margin yearly trend continues to be very stable with very little volatility. Operating Profit Margin is likely to grow to -0.14 this year.
Check Inogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.5 M, Interest Expense of 6.4 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 0.71, Dividend Yield of 0.0 or PTB Ratio of 1.36. Inogen financial statements analysis is a perfect complement when working with Inogen Valuation or Volatility modules.
  
Build AI portfolio with Inogen Stock
Check out the analysis of Inogen Correlation against competitors.
Evaluating Inogen's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Inogen Inc's fundamental strength.

Latest Inogen's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Inogen Inc over the last few years. It is Inogen's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inogen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (0.07) %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Inogen Operating Margin Regression Statistics

Arithmetic Mean(0.03)
Geometric Mean0.08
Coefficient Of Variation(486.73)
Mean Deviation0.11
Median0.02
Standard Deviation0.13
Sample Variance0.02
Range0.4593
R-Value(0.56)
Mean Square Error0.01
R-Squared0.32
Significance0.02
Slope(0.01)
Total Sum of Squares0.29

Inogen Operating Margin History

2026 -0.14
2025 -0.15
2024 -0.13
2023 -0.35
2022 -0.23
2021 0.0258
2020 -0.039

About Inogen Financial Statements

Inogen investors utilize fundamental indicators, such as Operating Margin, to predict how Inogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people.

Pair Trading with Inogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inogen Stock

  0.66AHC Austco HealthcarePairCorr
  0.612DR Inspire Medical SystemsPairCorr

Moving against Inogen Stock

  0.71VMD Viemed HealthcarePairCorr
  0.57QIPT Quipt Home MedicalPairCorr
  0.474DX 4DMEDICALPairCorr
  0.46TRLS Trellus Health plcPairCorr
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out the analysis of Inogen Correlation against competitors.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Health Care Equipment & Supplies sector continue expanding? Could Inogen diversify its offerings? Factors like these will boost the valuation of Inogen. Market participants price Inogen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.873
Earnings Share
(1.00)
Revenue Per Share
13.467
Quarterly Revenue Growth
0.04
Return On Assets
(0.06)
Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.